Ohio Bioscience News

Click a news item to be directed to the full story. Send your news to bioohio@bioohio.com.

Found 6929 Results

ONN TV pops in on some bioscience companies

Ohio News Network (ONN) reporter Denise Alex and video editor Theo Bursey visited TechColumbus yesterday, primarily to interview NanoFiber Solutions’ Jed Johnson for a piece on Ohio’s bioscience industry. They had time to visit with us at BioOhio, and we arranged some “fly by” interviews at Linebacker and EXCMR. We’ll embed the video once it airs.

January 4, 2012

Ohio venture capital growth ↑ 80%, eclipsing national growth rate

According to a recent study conducted by The Ohio State University’s Fisher College of Business, Ohio’s venture capital (VC) investments last year outpaced national levels by four to one. Nationally, there was $23.3 billion in venture capital investment — a 20% increase over 2009 levels. With $567.4 million invested in 2010, Ohio VC funding increased […]

December 29, 2011

Ohio boasts experts on human element of medical device design

Medical device industry publication, MD+DI, is running a series of articles this month discussing the human element of medical device design. The magazine began the series with two Q&A pieces featuring University of Cincinnati Biomedical Engineering Professor Mary Beth Privitera. Read part 1, “The Human Element: Designing the Devices Surgeons Want,” and part 2, “Pushing […]

December 27, 2011

Another Ohio-Ohio-Bio collaboration

BioOhio loves finding out when two (or more) Ohio companies are working together to commercialize a biomedical product. We encourage such in-state partnerships every chance we get. A recent Cincinnati Enquirer piece tells of the successful relationship between Milford-based Interplex Medical and Cervilenz in Chagrin Falls. We especially like this excerpt: CerviLenz, which is located […]

December 23, 2011

New Third Frontier RFPs released

Three new Ohio Third Frontier program RFP fact sheets have been released by the Ohio Department of Development. Industrial Research and Development Center Program 2012 RFP Entrepreneurial Signature Program (ESP) 2012 RFP Innovation Platform Program 2012 RFP Development staff have been holding Ohio Third Frontier informational sessions throughout the state in December. Remaining sessions for […]

December 22, 2011

Visits by Governor cap day of biomedical growth in northeast Ohio

The Plain Dealer summarizes job growth announcements made at Steris Corp. and Philips Healthcare yesterday. Pictured below, Gov. John Kasich (center) visits Philips Healthcare. At left is Jay Mazelsky, senior vice president and general manager for computed tomography and nuclear medicine. Jay also is a new BioOhio Board member.

December 21, 2011

Gov. Kasich in northeast Ohio today for expansion announcements at Philips Healthcare and STERIS

The Cleveland Plain Dealer is reporting that Gov. John Kasich will visit Philips Healthcare in Highland Heights and STERIS in Mentor for signficant announcements related to new jobs at both biomedical companies. Philips Healthcare plans to move 100 jobs to Highland Heights from San Jose, Calif. And Steris Corp., which makes medical-instrument sterilizers and other […]

December 20, 2011

AtriCure earns groundbreaking FDA approval

West Chester-based medical device company AtriCure (Nasdaq: ATRC) announced Friday that the FDA has approved their Synergy Ablation System for the treatment of atrial fibrillation (AF). Specifically, the Synergy Ablation System has been approved for the treatment of patients with persistent and long-standing persistent AF during open-heart procedures. This is the first time a surgical ablation […]

December 19, 2011

Austen BioInnovation Institute to partner with FDA on medical device safety initiatives

Today the Austen BioInnovation Institute in Akron (ABIA) and the U.S. Food and Drug Administration (FDA) executed a Memorandum of Understanding that will allow the FDA to draw upon ABIA resources to support the FDA’s safety review of biomaterials used in medical devices. Working with the FDA, ABIA will identify and convene a steering committee […]

December 15, 2011

ChanTest inks agreement with Roche to perform cardiac safety testing

Cleveland’s ChanTest Corporation, a leading ion channel screening provider, will soon be working with Roche’s Diagnostic Division to perform cardiac safety testing of potential drug compounds. ChanTest will use Roche’s xCELLigence RTCA Cardio Instrument and Cellular Dynamics International’s iCell Cardiomyocytes to measure pharmacological responses to a variety of compounds that have been selected based on […]

December 13, 2011